Search - tctmd.com

Displaying 1 - 20 of 50

Sort: Relevancy | Date

Presentation TCT 2025

European Transition from Medical Device Director (MDD) to Medical Device Regulation (MDR): Roadmap for the Future of Global AF Studies

Presenter: Philippe PM Garot

October 28, 2025

Presentation TCT 2025

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

Presenter: Robert T. Gerber

October 27, 2025

Presentation TCT 2025

TCT 1934: Fully Percutaneous Thrombectomy for Clot-in-Transit Across a Patent Foramen Ovale in Massive Pulmonary Embolism

Presenter: Matteo Sturla

October 26, 2025

Presentation TCT 2025

Timing the Transition: Hemodynamic Decompensation and MCS Candidacy in Heart Failure

Presenter: Cate Enstrom

October 25, 2025

Presentation TCT 2024

Wound Care Transition – Holistic Care for Transition from Inpatient to Outpatient

Presenter: Kimberly Campbell

October 27, 2024

Presentation TCT 2024

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

Presenter: Angelo Oliva

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Presentation TCT 2023

TCT 945: Conform WhenThings are Unconformable: Novel Utilization of Combined Thrombectomy Devices to remove a Massive Organized Clot-in-Transit

Presenter: Mohammad Akram Kawsara

October 25, 2023

Presentation TCT 2023

TCT 944: Sucessful Aspiration of Saddle Pulmonary Embolism and Thrombus in Transit via PFO

Presenter: Mouzam Faroqui

October 25, 2023

Presentation TCT 2023

How to Become/Be Successful As a Cath Lab Director

Presenter: Herbert Aronow

October 25, 2023

Presentation TCT 2023

Status Update on the Breakthrough Device Transitional Coverage for Emerging Technologies Program (TCET)

Presenter: Steven Farmer

October 24, 2023

Presentation TCT 2023

TCT 601: In-Hospital Outcomes of IVUS-Guided PCI Versus Angiography-Guided PCI: Is the Transition to Higher IVUS Utilization Improving Patient Outcomes?

Presenter: Daniel Lutz

October 24, 2023

Presentation TCT 2023

Transitional Coverage for Emerging Technologies (TCET): Stimulant for Innovations

Presenter: Steven Farmer

October 23, 2023

Presentation TCT 2022

R Sided Clot in Transit

Presenter: Matthew Finn

September 19, 2022

Presentation TCT 2022

Case 2: COVID Patient With Clot in Transit

Presenter: Matthew Finn

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

Presentation TCT 2020

TRANSIT: Treatment of Failed TAVR With TAVR

Presenter: Luca Testa

October 17, 2020

Advertisement

European Transition from Medical Device Director (MDD) to Medical Device Regulation (MDR): Roadmap for the Future of Global AF Studies

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

TCT 1934: Fully Percutaneous Thrombectomy for Clot-in-Transit Across a Patent Foramen Ovale in Massive Pulmonary Embolism

Timing the Transition: Hemodynamic Decompensation and MCS Candidacy in Heart Failure

Wound Care Transition – Holistic Care for Transition from Inpatient to Outpatient

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

What’s Going to Be Big at TCT 2024?

TCT 945: Conform WhenThings are Unconformable: Novel Utilization of Combined Thrombectomy Devices to remove a Massive Organized Clot-in-Transit

TCT 944: Sucessful Aspiration of Saddle Pulmonary Embolism and Thrombus in Transit via PFO

How to Become/Be Successful As a Cath Lab Director

Status Update on the Breakthrough Device Transitional Coverage for Emerging Technologies Program (TCET)

TCT 601: In-Hospital Outcomes of IVUS-Guided PCI Versus Angiography-Guided PCI: Is the Transition to Higher IVUS Utilization Improving Patient Outcomes?

Transitional Coverage for Emerging Technologies (TCET): Stimulant for Innovations

R Sided Clot in Transit

Case 2: COVID Patient With Clot in Transit

FLASH: More Data to Support Mechanical Thrombectomy in PE

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Failed MitraClip Is Uncommon, but Bleak When It Happens

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

TRANSIT: Treatment of Failed TAVR With TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content